| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |